ambenonium (Mytelase)

Introduction

Tradename: Mytelase. (ambenonium chloride)

Indications

treatment of myasthenia gravis

Dosage

5-25 mg PO TID-QID

Tabs: 10 mg

Adverse effects

• common (> 10%)
  • diarrhea
  • increased sweating
  • increased lacrimation
  • nausea
  • stomach cramps
• less common (1-10%)
  • urge to urinate, increased bronchial secretions, miosis
• uncommon (< 1%)
  • thrombophlebitis, bradycardia, AV-block, seizures, headache, dysphoria, drowsiness, muscle spasms, diplopia, laryngospasm, respiratory paralysis, hypersensitivity, hyper-reactive cholinergic responses, weakness

• drug adverse effects of cholinesterase inhibitors

More general terms

• cholinesterase inhibitor
• neurologic agent

Additional terms

• myasthenia gravis

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2131
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=8288